Frontiers in Drug Discovery is an Open Access journal publishing rigorously peer-reviewed research across disciplines and associated cutting edge technologies that are critical to the discovery and development of new drugs and therapies. Field Chief Editor Bruno Villoutreix at INSERM is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The covered drugs encompass a wide variety of agents, including small molecules and biologics.
We also welcome editorial submissions that explore topics such as personalized and stratified medicine, pharmacoeconomics, project mining, management and strategic planning, ecosystem mapping, public-private partnerships, academic drug discovery and translational medicine, training and education, empowering citizen and patients to contribute to the drug discovery process and increasing the awareness of politicians and mass medias about drug discovery
Frontiers in Drug Discovery is a member of the Committee on Publication Ethics.
Short Name: Front. Drug. Discov.
Electronic ISSN: 2674-0338
Indexed in: CLOCKSS, CrossRef, Google Scholar, OpenAIRE
Frontiers in Drug Discovery is composed of the following Specialty Sections:
The specialty sections of Frontiers in Drug Discovery welcome submission of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Systematic Review and Technology and Code.
When submitting a manuscript to Frontiers in Drug Discovery, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org